Skip to main content

Advertisement

Articles

Page 6 of 6

  1. We present our initial experience of allogeneic stem cell transplant procedure performed between April 2004 and August 2011 for various haematological disorders. All patients with non-malignant and malignant h...

    Authors: Natasha Ali, Salman Naseem Adil, Mohammad Usman Shaikh, Munira Moosajee and Nehal Masood

    Citation: Experimental Hematology & Oncology 2012 1:13

    Content type: Short report

    Published on:

  2. Hematopoietic stem cells (HSCs) are rare cells that have the unique ability to self-renew and differentiate into cells of all hematopoietic lineages. The expansion of HSCs has remained an important goal to dev...

    Authors: Jessica A Schuster, Maria R Stupnikov, Gina Ma, Wenbin Liao, Raymond Lai, Yupo Ma and Jerell R Aguila

    Citation: Experimental Hematology & Oncology 2012 1:12

    Content type: Review

    Published on:

  3. Liposomal formulations of anthracyclines appear to have favorable toxicity profile when compared with conventional anthracyclines in elderly, high risk cardiac patients and patients with prior use of anthracyc...

    Authors: Shamudheen M Rafiyath, Mohammad Rasul, Byung Lee, Guoqing Wei, Gurpreet Lamba and Delong Liu

    Citation: Experimental Hematology & Oncology 2012 1:10

    Content type: Research

    Published on:

  4. HevyLite™ is a new, recently developed method that facilitates separate quantification of the kappa- and lambda-bounded amounts of a given immunoglobulin (Ig). Using this method, we measured intact immunoglobu...

    Authors: Efstathios Koulieris, Panayiotis Panayiotidis, Stephen J Harding, Nikolitsa Kafasi, Dimitris Maltezas, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, George Georgiou, Ladan Mirbahai, Arthur R Bradwell and Marie-Christine Kyrtsonis

    Citation: Experimental Hematology & Oncology 2012 1:9

    Content type: Research

    Published on:

  5. A patient with acute lymphoblastic leukemia repeatedly developed hypoglycemia during chemotherapy. Comparison of serum glucose trends between chemotherapy with and without L-asparaginase (L-Asp) demonstrated a...

    Authors: Ryuma Tanaka, Tomoo Osumi, Masashi Miharu, Tomohiro Ishii, Tomonobu Hasegawa, Takao Takahashi and Hiroyuki Shimada

    Citation: Experimental Hematology & Oncology 2012 1:8

    Content type: Case report

    Published on:

  6. T-cell Prolymphocytic leukemia (T-PLL) is a rare post-thymic T-cell malignancy that follows an aggressive clinical course. The classical presentation includes an elevated white blood cell (WBC) count with anem...

    Authors: Michael Bellone, Annika M Svensson, Ann-Leslie Zaslav, Silvia Spitzer, Marc Golightly, Mahmut Celiker, Youjun Hu, Yupo Ma and Tahmeena Ahmed

    Citation: Experimental Hematology & Oncology 2012 1:7

    Content type: Case report

    Published on:

  7. This report describes the clinical courses of two acute myeloid leukemia patients. Both had MLL translocations, the first a t(10;11)(p11.2;q23) with MLL-AF10 and the second a t(11;19)(q23;p13.1) with MLL-ELL fusi...

    Authors: Thomas Burmeister, Mara Molkentin, Claus Meyer, Nils Lachmann, Stefan Schwartz, Birte Friedrichs, Jörg Beyer, Igor Wolfgang Blau, Gunnar Lohm, Carola Tietze-Bürger, Rolf Marschalek and Lutz Uharek

    Citation: Experimental Hematology & Oncology 2012 1:6

    Content type: Case report

    Published on:

  8. Angiogenesis is essential for promoting growth and metastasis of solid tumors by ensuring blood supply to the tumor mass. Targeting angiogenesis is therefore an attractive approach to therapeutic intervention ...

    Authors: Dazhong Xu, Qi Wang, Yongping Jiang, Yanxi Zhang, Eleazar Vega-SaenzdeMiera, Iman Osman and Wei Dai

    Citation: Experimental Hematology & Oncology 2012 1:5

    Content type: Review

    Published on:

  9. A growing body of evidence indicates that digitoxin cardiac glycoside is a promising anticancer agent when used at therapeutic concentrations. Digitoxin has a prolonged half-life and a well-established clinica...

    Authors: Hosam A Elbaz, Todd A Stueckle, William Tse, Yon Rojanasakul and Cerasela Zoica Dinu

    Citation: Experimental Hematology & Oncology 2012 1:4

    Content type: Review

    Published on:

  10. Oxidative stress and redox-regulating enzymes may have roles both in lymphomagenesis and resistance to lymphoma therapy. Previous studies from the pre-rituximab era suggest that antioxidant enzyme expression i...

    Authors: Pekka Peroja, Anna Kaisa Pasanen, Kirsi-Maria Haapasaari, Esa Jantunen, Ylermi Soini, Taina Turpeenniemi-Hujanen, Risto Bloigu, Laura Lilja, Outi Kuittinen and Peeter Karihtala

    Citation: Experimental Hematology & Oncology 2012 1:2

    Content type: Research

    Published on:

Annual Journal Metrics

On the blog

Advertisement